Scroll To Top
World

CDC Wants Only High-Risk MSM Using PrEP

CDC Wants Only High-Risk MSM Using PrEP

Truvada_1_1
Support The Advocate
LGBTQ+ stories are more important than ever. Join us in fighting for our future. Support our journalism.

The U.S. Centers for Disease Control have some caveats about pre-exposure prophylaxis treatment, which was recently found to dramatically lower HIV rates for men who have sex with men.

The CDC recently issued its first official guidelines on PrEP treatment after news broke in November that the therapy, involving the daily use of the AIDS drug Truvada, helps keep some people HIV-negative.

For more on this story, visit HIV Plus.

The Advocates with Sonia BaghdadyOut / Advocate Magazine - Jonathan Groff & Wayne Brady

From our Sponsors

Most Popular

Latest Stories

Advocate.com Editors